These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38799468)

  • 41. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis.
    Roche PW; Triccas JA; Avery DT; Fifis T; Billman-Jacobe H; Britton WJ
    J Infect Dis; 1994 Nov; 170(5):1326-30. PubMed ID: 7963739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled aerosol viral-vectored vaccines against tuberculosis.
    Stylianou E; Satti I
    Curr Opin Virol; 2024 Jun; 66():101408. PubMed ID: 38574628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.
    Ritz N; Mui M; Balloch A; Curtis N
    Vaccine; 2013 Jun; 31(30):3098-103. PubMed ID: 23583897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.
    Zhang M; Dong C; Xiong S
    Hum Vaccin Immunother; 2017 Apr; 13(4):816-822. PubMed ID: 27960596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
    Pi J; Zhang Z; Yang E; Chen L; Zeng L; Chen Y; Wang R; Huang D; Fan S; Lin W; Shen H; Xu JF; Zeng G; Shen L
    J Nanobiotechnology; 2022 Jan; 20(1):36. PubMed ID: 35033108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose.
    Zhang M; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():34. PubMed ID: 28224119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies and tuberculosis.
    Jacobs AJ; Mongkolsapaya J; Screaton GR; McShane H; Wilkinson RJ
    Tuberculosis (Edinb); 2016 Dec; 101():102-113. PubMed ID: 27865379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterologous Boosting With
    Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
    Front Immunol; 2020; 11():2036. PubMed ID: 32983151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
    Tameris M; Geldenhuys H; Luabeya AK; Smit E; Hughes JE; Vermaak S; Hanekom WA; Hatherill M; Mahomed H; McShane H; Scriba TJ
    PLoS One; 2014; 9(2):e87340. PubMed ID: 24498312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivated
    Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
    Front Immunol; 2019; 10():1588. PubMed ID: 31354727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.
    Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M
    Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S
    Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
    Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
    Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent developments in tuberculosis vaccines.
    Haile M; Källenius G
    Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.